<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01850264</url>
  </required_header>
  <id_info>
    <org_study_id>HDZNRW_KA_002_KJG</org_study_id>
    <nct_id>NCT01850264</nct_id>
  </id_info>
  <brief_title>Quartet™ Bad Oeynhausen Trial</brief_title>
  <acronym>QUOTA</acronym>
  <official_title>Quartet™ Bad Oeynhausen Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart and Diabetes Center North-Rhine Westfalia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective of this study is to evaluate whether the use of a quadripolar left
      ventricular (LV) electrode compared to a standard bipolar LV electrode leads to lower
      non-responder rates in patients undergoing cardiac resynchronization therapy (CRT)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in peak oxygen consumption</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of New York Heart Association (NYHA) functional class</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Congestive Heart Failure</condition>
  <condition>Cardiac Resynchronization Therapy</condition>
  <arm_group>
    <arm_group_label>Quadripolar LV electrode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of a quadripolar LV electrode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bipolar LV electrode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of a bipolar LV electrode</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Application of quadripolar / bipolar LV electrodes</intervention_name>
    <arm_group_label>Quadripolar LV electrode</arm_group_label>
    <arm_group_label>Bipolar LV electrode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for CRT-D implantation according to current guidelines

          -  Ischemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM)

          -  Sinus rhythm

          -  NYHA II-IV

          -  Age ≥ 18 years

          -  Written informed consent to participate in the study

        Exclusion Criteria:

          -  Right bundle brunch block

          -  Valvular cardiomyopathy

          -  Patient receiving a non-transvenous LV electrode

          -  Known pregnancy

          -  Age &lt; 18 years

          -  Life expectancy &lt; 1 year

          -  Atrial fibrillation / atrial flutter at the time of enrolment

          -  Inability to provide informed consent

          -  Participation in another study with active therapeutic arm

          -  Regular follow-up in the study center within the first 6 months after implantation not
             guaranteed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus-Juergen Gutleben, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart and Diabetes Center North Rhine-Westphalia, Department of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Klaus-Juergen Gutleben, M.D.</last_name>
    <phone>49 5731</phone>
    <phone_ext>971327</phone_ext>
    <email>kjgutleben@hdz-nrw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Astrid Kleemeyer</last_name>
    <phone>49 5731</phone>
    <phone_ext>971258</phone_ext>
    <email>akleemeyer@hdz-nrw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Klaus-Juergen Gutleben, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georg Noelker, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bogdan G Muntean, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2013</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart and Diabetes Center North-Rhine Westfalia</investigator_affiliation>
    <investigator_full_name>Klaus Juergen Gutleben</investigator_full_name>
    <investigator_title>Senior cardiologist</investigator_title>
  </responsible_party>
  <keyword>cardiac resynchronization therapy; heart failure, congestive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

